How certain brain receptors control dopamine and serotonin cells
Regulation of monoamine neurons by delta glutamate receptors
Researchers are looking at how a type of brain receptor helps dopamine, norepinephrine, and serotonin cells fire, which could affect mood and addiction.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Iowa NIH-funded |
| Lab location | 1 site (Iowa City, United States) |
| Project ID | NIH-11258047 on NIH RePORTER |
What this research studies
This work looks inside brain cells that make dopamine, norepinephrine, and serotonin to see how certain 'delta' glutamate receptors control their electrical activity. Scientists will use lab experiments including recordings of nerve-cell activity and animal models to study two types of signals the receptor carries — a fast, receptor-linked signal and a steady 'tonic' current. They aim to find the molecular steps that let G-protein signaling turn the receptor on and to explain why the receptor also provides a constant depolarizing current. Understanding these mechanisms could point to new ways to adjust monoamine firing in conditions like depression, anxiety, and addiction.
Who could benefit from this research
Good fit: People with depression, anxiety disorders, or substance use problems would be most likely to benefit from therapies that come from this work.
Not a fit: People whose symptoms are unrelated to serotonin, dopamine, or norepinephrine signaling—such as those from structural brain injury—are less likely to benefit.
Why it matters
Potential benefit: If successful, this work could reveal new drug targets to improve treatments for depression, anxiety, and substance use disorders.
How similar studies have performed: Previous laboratory studies have shown receptor coupling can change neuron firing, but translating these basic findings into patient treatments is still new.
Where this research is happening
Iowa City, United States
- University of Iowa — Iowa City, United States (Active)
Researchers
- Principal investigator: Gantz, Stephanie C. — University of Iowa
- Study coordinator: Gantz, Stephanie C.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.